Almac has launched its Direct to Patient shipping service for clinical trials, which enhances the existing clinical trial distribution service provided by Almac by coordinating all clinical trial (including temperature and non-temperature controlled) material shipments from clinical sites directly to patient's homes throughout the US and Canada. Due diligence has been performed to ensure adherence with US federal, state and Canadian regulations.

This service offers clinical trial patients enhanced flexibility as it works around their personal convenience and improves the patient experience by reducing on-site clinic visits. In addition patients no longer have to travel to clinical sites for all of their visits thereby reducing associated costs and drop-out rates. The Direct to Patient service implemented by Almac is in response to increasing sponsor demand and enables trial sponsors to move closer to the patients participating in the trials, regardless of their proximity to study sites.

Source: Almac